megestrol has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, ST; Ong, S; Quek, R | 1 |
| Dahrouge, S; Stewart, DJ | 1 |
| Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH | 1 |
| Azab, M; Blomqvist, C; Buzdar, A; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Plourde, PV; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Azab, M; Blomqvist, C; Eiermann, W; Hellmund, R; Howell, A; Jonat, W; Lundgren, S; Mauriac, L; Roche, H; Tyrrell, C; Winblad, G | 1 |
| Osborn, JL; Smith, DC; Trump, DL | 1 |
| Blomqvist, CP; Buzdar, AU; Eiermann, W; Howell, A; Jonat, W; Jones, SE; Lee, D; Steinberg, M; Vogel, CL; Webster, A; Wolter, JM | 1 |
| Bonner, JA; Klee, GG; Krook, JE; Kugler, JW; Mailliard, JA; Maksymiuk, AW; Marks, RS; Perez, EA; Rowland, KM; Shaw, EG; Sloan, JA; Wiesenfeld, M | 1 |
| Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Soong, YK; Wang, CB; Wang, CJ | 1 |
5 trial(s) available for megestrol and Disease Exacerbation
| Article | Year |
|---|---|
Serial serum c-erbB-2 levels in patients with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome | 1996 |
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Prognosis; Survival Rate; Tamoxifen; Triazoles | 1996 |
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol; Middle Aged; Nitriles; Postmenopause; Prospective Studies; Quality of Life; Remission Induction; Survival Rate; Triazoles | 1996 |
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Megestrol; Nitriles; Postmenopause; Proportional Hazards Models; Survival Rate; Triazoles | 1998 |
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Megestrol; Middle Aged; Neoplasm Staging; Phosphopyruvate Hydratase; Survival Rate; Time Factors | 2000 |
4 other study(ies) available for megestrol and Disease Exacerbation
| Article | Year |
|---|---|
Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Hepatocellular; Deoxycytidine; Disease Progression; Fluorouracil; Humans; Male; Megestrol; Thalidomide; Treatment Outcome | 2006 |
Response of brain metastases from breast cancer to megestrol acetate: a case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local | 1995 |
Megestrol acetate in the treatment of hormone refractory prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Disease Progression; Drug Monitoring; Drug Resistance, Neoplasm; Humans; Male; Megestrol; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Treatment Failure | 1997 |
Fertility-preserving treatment in young patients with endometrial adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Disease Progression; Endometrial Neoplasms; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Megestrol; Megestrol Acetate; Pelvis; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome; Ultrasonography | 2002 |